TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.10
+0.01 (+0.48%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+465.7% upside
Low Target
$7.57
Average Target
$11.88
High Target
$17.16
Current Price
$2.10
Current
$2.10
$2.10
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Scenario Analysis
Bear Case
$7.57
260.5%
Low target
Base Case
$11.88
+465.7%
Avg target
Bull Case
$17.16
+717.1%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$2.95
-28.8% from high
52-Week Low
$0.99
+112.1% from low
Target vs 52W High
$11.88
+302.7% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals